BioTelemetry (BEAT) Tops Q1 EPS by 1c; Raises Revenue Otulook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
BioTelemetry, Inc. Reports First Quarter 2019 Financial Results
April 25, 2019 4:05 PM EDTAchieves Record Quarterly Revenue
Raises Full Year 2019 Guidance
MALVERN, Pa., April 25, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2019.
Quarter Highlights
Recognized record quarterly revenue of $104.0 millionReached 10.0% year-over-year revenue growthAchieved 27th consecutive quarter of year-over-year revenue growthReported GAAP net income of $11.7 millionRealized quarterly adjusted EBITDA of $28.8 million, or 27.7% of... More